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Abstract
The protozoan intestinal parasite Entamoeba histolytica infects millions of people worldwide and is capable of causing
amebic dysentery and amebic liver abscess. The closely related species Entamoeba dispar colonizes many more individuals,
but this organism does not induce disease. To identify molecular differences between these two organisms that may
account for their differential ability to cause disease in humans, we used two-dimensional gel-based (DIGE) proteomic
analysis to compare whole cell lysates of E. histolytica and E. dispar. We observed 141 spots expressed at a substantially (.5-
fold) higher level in E. histolytica HM-1:IMSS than E. dispar and 189 spots showing the opposite pattern. Strikingly, 3 of 4
proteins consistently identified as different at a greater than 5-fold level between E. histolytica HM-1:IMSS and E. dispar were
identical to proteins recently identified as differentially expressed between E. histolytica HM-1:IMSS and the reduced
virulence strain E. histolytica Rahman. One of these was E. histolytica alcohol dehydrogenase 3 (EhADH3). We found that E.
histolytica possesses a higher level of NADP-dependent alcohol dehydrogenase activity than E. dispar and that some
EhADH3 can be localized to the surface of E. histolytica. Episomal overexpression of EhADH3 in E. histolytica trophozoites
resulted in only subtle phenotypic differences in E. histolytica virulence in animal models of amebic colitis and amebic liver
abscess, making it difficult to directly link EhADH3 levels to virulence differences between E. histolytica and less-pathogenic
Entamoeba.
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Introduction
Entamoeba histolytica, a protozoan intestinal parasite, is the
causative agent of amebic dysentery and amebic liver abscess
[1], and is one of the leading causes of death from parasitic
diseases. The closely related species, Entamoeba dispar, is morpho-
logically indistinguishable from E. histolytica [2], and is highly
prevalent in areas of poor sanitation. Importantly, E. dispar is a
commensal and does not cause disease in humans, even in
immunocompromised individuals. Previous studies have identified
a number of Entamoeba molecules that appear to be linked to
virulence, including cysteine proteinases, amoebapores, the Gal/
GalNAc lectin and peroxiredoxin, but the virulence phenotype is
unlikely to be secondary to only one, or even a few proteins [1,3–
8]. The ability to compare the genome and proteome of E.
histolytica, and the related but nonpathogenic E. dispar, provides a
powerful platform for more widespread screening for additional
virulence factors of E. histolytica. Here we report the use of
comparative proteomics of E. histolytica HM-1:IMSS and E. dispar
SAW760 to identify proteins that are differentially expressed
between the two species, and the characterization of one of the
differentially expressed proteins, EhADH3, identified by this
screen.
Materials and Methods
Entamoeba species
E. histolytica HM-1:IMSS and E. dispar SAW760 were grown
axenically in LYI-S-2 with 15% adult bovine serum medium at
London School of Hygiene and Tropical Medicine [9]. For
proteomic analysis, approximately 56106 E. histolytica or E.
dispar trophozoites were harvested and washed 3 times in ice-
cold PBS to remove serum and medium proteins, then lysed in
a buffer formulated to minimize post-lysis proteolysis (7 M
Urea, 2 M thiourea, 4% CHAPS, 30 mM Tris, 5 mM
magnesium acetate, 16 Roche Complete protease inhibitor
cocktail with EDTA). Lysates were frozen at 280uC before
analysis [3].
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2-D difference gel electrophoresis (DIGE) and protein
identification using tandem mass spectrometry
Trophozoite lysates were analyzed as previously described [3].
Briefly, lysates were thawed on wet ice and labeled with either Cy3
or Cy5 (GE Healthcare, Piscataway, NJ, USA) and quenched with
lysine. The quenched Cy-labeled samples were then combined and
added to an equal volume of 26 rehydration buffer (7 M urea,
2 M thiourea, 4% CHAPS, 4 mg/ml DTT) supplemented with
0.5% IPG (Immobilized pH gradient, GE Healthcare) buffer 3–11.
Labeled protein extracts were separated by standard 2D gel
electrophoresis. Following second-dimension focusing, the gel was
fluorescently scanned using a Typhoon 9400 variable mode
imager (GE Healthcare) to detect Cy3- and Cy5-specific emissions
corresponding to protein concentration [10]. Fluorescent gel
images were then analyzed using Decyder software (GE
Healthcare), where individual spot volume ratios were calculated
for each protein spot pair.
Gel features were selected in the DeCyder software, then
excised and transferred to a 96-well source plate. The gel pieces
were digested in situ with trypsin as previously described [11].
Spectra of the peptide pools were obtained on a MALDI-TOF/
TOF instrument (ABI 4700) and operated as previously described
[12] using peptides from trypsin autolysis (m/z=842.51, 1045.56,
and 2211.10) [13] for internal calibration. The most intense MS
signals (n = 7–20) were automatically selected for tandem mass
spectrometry using the MALDI-TOF/TOF instrument after
exclusion of observed m/z values from contaminants. The peptide
fragmentation spectra were processed (centroiding and back-
ground subtraction) with GPS Explorer and searched using
MASCOT, V1.9 (Matrix Sciences, London) against the NCBI
non-redundant database (26-07-2005 build date), which contains
the published genome of E. histolytica.
Peptide pools from the gel features that were not identified using
MALDI-MS/MS were analyzed using capillary reversed-phase
HPLC-MS/MS using an electrospray-quadrupole time-of-flight
mass spectrometer (Q-STAR XL, Applied Biosystems). Peptide
pools from gel features that remained unidentified by either
MALDI-MS/MS or quadrupole-TOF-LC-MS/MS were ana-
lyzed using nano-LC-linear-quadrupole ion trap Fourier transform
ion cyclotron resonance mass spectrometry as previously described
[14]. Identifying peptide information for the 4 proteins discussed
in the text can be found in Table 1.
Expression and purification of recombinant EhADH3
Primers derived from the sequence of EhADH3 (Z48752.1)
[15], forward -AAGGATCCATGACAATGCTTAATTTCA-
CATA and reverse - TTCTCGAGTTAATAAATGCTATTAA-
GAATTTGGAGAT were used to amplify a EhADH3 transcript
from HM-1:IMSS genomic DNA. The fragment was inserted into
pCR 2.1 TOPO vector (TOPO TA Cloning Kit from Invitrogen,
Carlsbad, CA), cut by BamHI and XhoI and cloned into pGEX-
6p-1. The plasmid was expressed under 0.05 mM IPTG induction
in BL21- Codon Plus RIL from Stratagene (La Jolla, CA) at 18uC
under shaking at 250 rpm for 48 h.
To purify recombinant EhADH3, 1 L of the transfected BL-21
Escherichia coli cells were harvested by centrifugation at 1,5006g for
30 minutes 4uC and resuspended in 35 ml PBS with a Protease
Inhibitor Cocktail Tablet from Roche (Indianapolis, IN). The cell
suspension was passed through a French press twice at 12,000 PSI,
and then centrifuged at 20,0006g for 30 minutes at 4uC. The
supernatants were frozen at 280uC for later use. For purification
on the GST column, 500 ml supernatant was thawed overnight at
4uC, filtered with a 0.22 um filters from MilliPore (Temecula,
CA), and loaded on a B-PER GST Fusion Protein Purification Kit
from Pierce (Rockford, IL) according the manufacturer’s instruc-
tions. Following column washings with 200 ml PBS, 10 ml Wash
Buffer 1, 10 ml Wash Buffer2 and 10 ml PBS, 1.5 ml PBS
containing 120 ul PreScission Protease from GE Healthcare was
added to the column and incubated overnight at 4uC. The column
was eluted with 1 ml PBS, and the total volume (2.5 ml)
containing partially purified EhADH3 was dialyzed against
25 mM MES pH 6.0 (Buffer A) overnight at 4uC. This material
was then loaded onto a Resource Q ion exchange column from
GE Healthcare. After column washes with Buffer A, EhADH3 was
eluted by a salt gradient created by the addition of increasing
amounts (0% to 100%) of Buffer B (Buffer A with 1 M NaCl) to
Buffer A run over the column over 30 minutes at flow rate 2 ml/
min. Every 2 ml fraction was analyzed at UV 260 nm for protein
concentration and those with the highest OD were pooled,
dialyzed against 10 mM Tris HCl pH 7.3 and then concentrated
by Amicon Ultra-4 Centrifugal Filter Units from MilliPore. Purity
of the recombinant EhADH3 was assessed by SDS-PAGE.
Determination of the ADH Activity in E. histolytica or E.
dispar lysates, and analysis of the alcohol preference for
recombinant EhADH3
E. histolytica or E. dispar lysates used for analysis of alcohol
dehydrogenase activity were prepared as previously described
[16]. Two hundred micrograms (total protein) of lysate or 10 ug
of purified recombinant EhADH3 were added to a cuvette
containing containing 50 mM Glycine/NaOH, pH 9.5, 50 mM
MgSO4, 60 mM DTT, 0.2 mM NADP and 0.1 M of the
substrate alcohol to a final volume of 1 ml. The rate of increase
in absorbance was observed at 340 nm (1 OD=6.22 mM cm21
Table 1. Comparison of NADP-dependent alcohol
dehydrogenase activity in lysates of E. dispar, E. histolytica HM-
1:IMSS, and E. histolytica HM-1:IMSS overexpressing EhADH3
(HAO).
NADP-dependent ADH
activity E. dispar HM-1:IMSS HAO
Units/mg 0.036.021 0.2460.112 0.8560.31
Units/mg represents the enzyme activity (conversion of 1 mmole NADPH/min/
mg of lysate protein using ethanol as substrate) within the lysates.
1P#0.004 for the difference in activity between lysates from E. dispar and E.
histolytica HM-1:IMSS.
2P,0.001 for the difference in activity between lysates from E. histolytica HM-
1:IMSS and HAO.
doi:10.1371/journal.pntd.0000415.t001
Author Summary
Infection with Entamoeba histolytica can result in disabling
diarrhea or even death, while the morphologically identical
and genetically similar Entamoeba dispar harmlessly
colonizes the human intestine. Understanding the molec-
ular differences between these two organisms by com-
paring their protein repertoire may help us to understand
why E. histolytica invades into colonic tissue, while E. dispar
remains a benign passenger. Here, we identify four
proteins that appear to be differentially expressed
between the two species and show that a metabolic
enzyme, which would appear to be an unlikely candidate
for a role in disease, is expressed at much higher levels in
the pathogenic organism.
Proteomic Comparison of Entamoeba
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NADPH). A unit of enzyme activity was defined as one
micromole of product formed per minute of incubation at room
temperature.
Transfection
In order to overexpress EhADH3 in strains E. histolytica HM-
1:IMSS and E. histolytica Rahman, plasmid pNeoCass was used to
construct plasmid pNeoADH3 [17]. KpnI and BamHI sites on
pNeoCass were restricted, and the following primers were used to
amplify EhADH3 from E. histolytica HM-1:IMSS cDNA: Forward-
59 -AATTGGTACCATGACAATGCTTAATTTCACATAT-
TAC - 39, Reverse: 59 - ATCCGGATCCTTAATAAATGT-
CATTAAGAATTTGGAG - 39. The insert was then cut and
ligated into pNeoCass yielding pNeoADH3. Transfection was
performed as previously described [18]. Briefly, 16106 amebae
were washed 26 with cold PBS, and once with cold, fresh
cytomyx. The amebae were resuspended with 800 ul cytomyx and
60 ug DNA into a chilled 0.4 cm electroporation cuvette. A
BioRad GenePulser XCell was set to 25 uF and 3000 V/cm. Two
successive pulses were completed 30 s apart, and then amebae
were placed in medium and grown for 72 h before G418 drug
selection. These strains were maintained in culture medium BI-S-
33 containing G418 as previously described [19].
Live immunofluorescence staining
Approximately 26105 amebae were grown to log phase, chilled,
pelleted at 4uC and 4006g for 1 min, and resuspended in 2 ml
resuspension/blocking buffer, which consists of 50% v/v TYI-S-
33 [9] minus antibiotics and bovine serum, 50% v/v PBS with
20% heat-inactivated pooled goat sera (Sigma-Aldrich, St. Louis,
MO), and 0.02 mM E-64 protease inhibitor (Sigma-Aldrich), for
10 min at 4uC. Amebae were pelleted as before and resuspended
in 400 ul resuspension buffer with 1:100 polyclonal rabbit anti-
EhADH3 (AnaSpec, San Jose, CA). For specificity studies, the
1:100 anti-EhADH3 antibody was first incubated with 10 ug/mL
purified recombinant EhADH3 for 1 h at 37uC prior to addition
to the cell pellet. After 20 min incubation at 4uC, amebae were
washed 36as before with resuspension buffer. The pellet was then
resuspended in 400 ul resuspension buffer with 1:200 highly-
adsorbed goat anti-rabbit IgG-AlexaFluor 488 conjugate (Invitro-
gen, Carlsbad, CA). Amebae were incubated for 20 min at 4uC,
washed 36 with resuspension buffer, then once at 4uC with 16
PBS. The pellet was then resuspended in 4% paraformaldehyde in
16 PBS at 37uC for 1 h. Fixed, pelleted amebae were then
resuspended in 1 drop of Slowfade Gold with DAPI (Invitrogen)
and applied to a microscope slide. Microscopic images were
captured under 636oil-immersion magnification using a LSM510
Laser Scanning Confocal microscope (Carl Zeiss, Thornwood,
NY). Antibody-blocked and unblocked images were captured
using identical intensity settings.
SCID mouse model of amebic liver abscess
All our research on mice was approved by the Washington
University Animal Studies Committee (ASC), and was conducted
under AAALAC and USDA guidelines. For studies of amebic liver
abscess, 16106 E. histolytica HM-1:IMSS or E. histolytica Rahman
trophozoites overexpressing EhADH3 or an equivalent number of
the parental control cells were directly inoculated into the liver of
male, 6 to 8 weeks old BALB/c or SCID mice, as previously
described [20]. After 24 h, animals were sacrificed, and the livers
Figure 1. 2D-DIGE comparison of two E. histolytica HM-1:IMSS strains. 2852 spots were identified in this gel representing whole cell lysates
from two strains of E. histolytica HM-1:IMSS separately prepared. One was maintained in Saint Louis, Missouri, USA, and the other in London, England.
Using a three-fold cutoff, only 6 labeled protein spots were found to fluoresce at different levels, suggesting limited biological variation exists
between preparations and isolates. White spots are indicative of identical protein amounts; blue represents increased abundance in the Saint Louis
isolate, while yellow represented increased abundance in the London isolate.
doi:10.1371/journal.pntd.0000415.g001
Proteomic Comparison of Entamoeba
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were removed and weighed. The abscessed region of the liver was
cut out and weighed, and the percentage of liver abscessed was
calculated.
SCID-hu mouse model of colonic disease
Severe combined immunodeficient mice were engrafted in the
subscapular region with human colonic xenografts as previously
described [21]. Grafts were infected with an intraluminal
inoculation of 16106 trophozoites (either the parental wild type
strain, the pNeo control strain, or E. histolytica HM-1:IMSS or E.
histolytica Rahman over-expressing EhADH3) and infection was
assessed 24 h later. To measure the integrity of the intestinal
permeability barrier, 20 h after infection human intestinal
xenografts were intraluminally inoculated with fluoresceinated
dextran, and serum levels of fluoresceinated dextran were
measured using a fluorescent plate reader 4 h later [22]. Grafts
were removed at the time of sacrifice, and levels of MPO (as a
marker for the influx of inflammatory cells into the graft) were
measured according to our previously described assay [22]. For
histologic analysis, sections of the human intestinal xenograft were
fixed in formalin, sectioned and stained with haematoxylin and
eosin as previously described [21].
Results/Discussion
DIGE proteomic comparison of whole cell lysates is
reproducible and varies little between E. histolytica HM-
1:IMSS isolates
Two-dimensional difference gel electrophoresis (2D-DIGE)
allows protein lysates to be fluorescently labeled in such a way
as to allow visualization of multiple channels representing up to
three biological samples in a single physical gel while maintaining
the ability to analyze chosen protein spots using modern mass
spectrometric techniques [23]. The power of DIGE technology is
based on the elimination of false signals created when comparing
biological samples across separate acrylamide gels. In the past,
DIGE analysis has been useful in understanding changes to
biological systems following the application of drug or other
stimuli, or to compare cancerous and precancerous tissue [24].
However, only a few recent efforts have been directed at
comparing different species or strains of organisms [25]. The
difficulties involving cross-species analysis using two-dimensional
gel electrophoresis are not insignificant. Genomic differences
resulting in amino acid substitutions, splice variants, post-
translational modifications, truncations, or insertions can affect
whether a protein spot location accurately reflects the coordinates
of both species’ protein due to resultant differences in molecular
weight and isoelectric point. In addition, if complete genomic
information is not available for one or both of the species under
comparison, it may be difficult to identify those cases where the
primary amino acid structure of a given protein differs significantly
between the species. These issues were felt to be factors in a recent
attempt to use conventional 2-dimensional gels to delineate
proteomic differences between E. histolytica and E. dispar [26].
The recent progress on the genome of both E. histolytica and E.
dispar has significantly reduced, but not completely eliminated
these issues for this comparison.
To test the reliability of the DIGE approach, we first performed
comparative DIGE on identical samples of E. histolytica HM-
1:IMSS lysates, varying only the concentration of protease
inhibitor added to the cell lysate (doubled in the second sample
aliquot). No differences in spots were observed when a cutoff of 3-
fold difference in fluorescent intensity was used, indicating that
inter-sample full-length protein level differences secondary to
endogenous proteases were not important at these protease
inhibitor concentrations. To measure potential differences in spots
based on sample preparation, lysates from the same E. histolytica
HM-1:IMSS isolate were captured one week apart, both in the
logarithmic phase of growth. Again, with a 3-fold cutoff for
differences, only 1 protein spot differed from more than 2800
Figure 2. Representative 2D-DIGE gel of E. histolytica and E. dispar lysates demonstrating the extent of differences between species.
One representative gel image of DIGE comparisons between E. histolytica and E. dispar highlights the measured differences in fluorescently labeled
protein abundance between these two species. Yellow identifies protein spots that were proportionately higher in E. dispar; blue represents
increased abundance in E. histolytica; white represents equal signal. Proteins were identified as follows (see Table 1): 1: ADH2- Higher in E. histolytica
6.16; 2: ADH3- Higher in E. histolytica 5.86; 3: Grainin 2- Higher in E. dispar 9.66; 4: LIM domain protein- Higher in E. histolytica 12.66.
doi:10.1371/journal.pntd.0000415.g002
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Figure 3. Peptide data from observed proteomic differences between E. histolytica and E. dispar.
doi:10.1371/journal.pntd.0000415.g003
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computationally indexed spots (a five-fold cutoff reduces the
number of observed differences to zero). Finally, we compared
lysates from E. histolytica HM-1:IMSS separately maintained in two
distant laboratories (‘‘Saint Louis’’ and ‘‘London’’) using separate
growth media (Figure 1). Out of nearly 2900 spots, only 6 differed
using a 3-fold cutoff (1 differed at a 5-fold cutoff). These 6 spots
were not identified by mass spectroscopy, but based on gel location
they were not the same as those subsequently identified in this E.
histolytica and E. dispar comparative study (Figure 1). These data
indicate that the differences observed between species in the DIGE
experiment are unlikely to be due to random proteolysis,
differences in clonal populations, medium, or lysate preparation.
This is especially true when a strict cut-off of 5-fold is used to
identify differences between two samples derived from separate
species.
Proteomic comparison of E. histolytica HM-1:IMSS and E.
dispar SAW760 using DIGE
We used 2D-DIGE to compare the proteomes of E. histolytica
HM-1:IMSS and E. dispar SAW760. We were able to resolve an
average of 2676 spots (+/2109 spots) in three 2-D gels each
containing distinct biological replicates of lysates from each
species. The number of differentially expressed spots was a
function of the cut-off used for differential expression, but
requiring a minimum of 5-fold differential expression yielded an
average of 141 (+/216) spots expressed at a higher level in E.
histolytica HM-1:IMSS than E. dispar, with an average of 189 (+/
242) spots showing the opposite pattern. Figure 2 is an image of
one representative gel. Selecting only a subset of these results for
mass spectrometric analysis and using the strictest criteria (5-fold
or greater difference in intensity, and spots that were reproducibly
identified by mass spectrometry in at least two replicates) we found
4 proteins that could be unequivocally identified that showed
differential expression between E. histolytica HM-1:IMSS and E.
dispar SAW760 (see Table 1 for peptide identification).
Three proteins were present at higher levels in E. histolytica HM-
1:IMSS, and one was found at higher levels in E. dispar (Figure 2).
Strikingly, three of these proteins were identical to ones identified
as differentially expressed in the proteomic comparison between E.
histolytica HM-1:IMSS and the less virulent strain E. histolytica
Rahman (Figure 3) [3]. The novel protein grainin 2 (gi67468715)
was expressed at higher levels in E. dispar than in E. histolytica HM-
1:IMSS, with an average increase of 11.8-fold. Grainins are
calcium binding proteins of unknown function found in E.
histolytica granules [27]. A homology search of the provisional E.
dispar genomic database [28] showed the inferred homologous E.
dispar protein is 94% identical and 98% similar to the E. histolytica
protein (EDI_060410). We postulate that increased grainin levels
may contribute to a reduced virulence phenotype, since grainin
levels were decreased in trophozoites recently obtained from
amebic liver abscesses, and were higher in the proteome of the
reduced virulence strain E. histolytica Rahman compared to E.
histolytica HM-1:IMSS [3,29]. The finding that grainin 2 is
expressed at significantly higher levels in E. dispar compared to
E. histolytica is consistent with this hypothesis.
One of the proteins expressed at higher levels (average of 14.1-
fold) in E. histolytica compared to E. dispar was a protein containing
a LIM domain (gi67483283) (Figure 3). The LIM domain is a
cysteine and histidine rich domain composed of two zinc fingers.
LIM domains mediate protein-DNA and protein-protein interac-
tions and function in tissue differentiation, cytoskeletal rearrange-
ments, and other regulation of transcription [30]. A search of the
provisional E. dispar sequence database yielded a truncated gene
(77% complete) which is 99% identical to the E. histolytica gene
Figure 4. The gel area and spot representing ADH3 from one
representative DIGE gel. The right panel is a fluorescent intensity
scan of E. histolytica; the identical region from E. dispar is on the left. The
outlined spot was identified as ADH3 by mass spectrometry. The
demarcated region was used to calculate the signal fold difference
between the species’ ADH3 protein abundance, which was 5.82-fold
higher in E. histolytica than E. dispar in this gel.
doi:10.1371/journal.pntd.0000415.g004
Figure 5. Anti-ADH3 Western blot confirms the difference
between ADH3 protein abundance between species. Polyclonal
antibodies developed against recombinant EhADH3 were generated in
rabbits, and used to stain amebic lysates on a 1D Western blot.
Densitometric analysis, normalized against the amount of actin present
in each species’ sample, results in 5.4-fold more ADH3 in E. histolytica
compared to E. dispar. To the right of each image is MagicMark XP
(Invitrogen, Carlsbad, CA) marking the following ascending molecular
weights: 20 kD, 30 kD, 40 kD, 50 kD, 60 kD, 80 kD, 100 kD, and 120 kD.
doi:10.1371/journal.pntd.0000415.g005
Proteomic Comparison of Entamoeba
www.plosntds.org 6 April 2009 | Volume 3 | Issue 4 | e415
(EDI_092410). In addition, the full length E. histolytica gene is
nearly identical to the LIM domain protein found elevated in E.
histolytica strain HM-1:IMSS when compared to strain E. histolytica
Rahman [3].
The two other proteins found at higher levels in E. histolytica
HM-1:IMSS than E. dispar were alcohol dehydrogenase 2 and
alcohol dehydrogenase 3 (gi2492737 and gi2492738, respectively)
(Figure 3). This finding was of interest, given a prior report that a
virulent strain of E. histolytica showed higher alcohol dehydroge-
nase activity than a less virulent strain [15]. E. histolytica alcohol
dehydrogenase 2 (EhADH2) [31,32] is a NADH and iron-
dependent bifunctional alcohol dehydrogenase and acetaldehyde
dehydrogenase whose activity is absolutely required for E. histolytica
fermentation, growth and survival [16]. EhADH2 was originally
isolated as a laminin-binding protein from E. histolytica lysates, but
there is no direct experimental evidence that it serves this function
in vivo [31].
Characterization of E. histolytica ADH3
E. histolytica alcohol dehydrogenase 3 is an NADPH- dependent
alcohol dehydrogenase whose physiologic role in E. histolytica
metabolism remains unknown [33]. The most recent E. histolytica
resequencing data show that EhADH3 has no closely related
inparalog (the closest, EHI_088020 is only 70% identical),
differing from initial reports suggesting multiple copies of this
gene. Our DIGE analysis (Figure 4) indicated an average increase
of 8.6-fold in EhADH3 levels in E. histolytica compared to two
nearly identical E. dispar homologs (EDI_307670 and EDI_09820)
which are 90% identical and 95% similar to EhADH3 in derived
amino acid sequence. This difference in expression was confirmed
by immunoblotting using polyclonal sera that showed EhADH3
was present at 5.4-fold higher levels in E. histolytica compared to E.
dispar by densitometry (Figure 5). Additionally, we recently found
that EhADH3 is present at significantly higher levels in E. histolytica
HM-1:IMSS than the reduced-virulence E. histolytica Rahman, and
here there was no amino acid sequence difference between the
predominant EhADH3 allele in E. histolytica HM-1:IMSS and E.
histolytica Rahman [3]. Taken as a whole, these data are consistent
with E. histolytica EhADH3 (gi2492738), being present at higher
levels in E. histolytica than its close homologues in E. dispar, but we
cannot exclude the possibility than other more distant alleles of
EhADH3 and EdADH3 could show different expression patterns.
To determine whether there is physiologic evidence that ADH3
levels are higher in E. histolytica than E. dispar, we first analyzed
purified recombinant EhADH3 to determine the optimal substrate
specificity for the ADH3 enzyme. As shown in Figure 6, we found
that EhADH3 prefers short chain unbranched alcohols as
substrates, with the most activity using butanol. These data
differentiate it from the NADP-dependent EhADH1 protein
described by Kumar et al. [34], which preferred branched chain
alcohols (2-propanol). We then measured the NADP-dependent
ADH activity using ethanol as substrate in lysates from E. histolytica
and compared it to that found in protein-matched lysates from E.
dispar. As shown in Table 1, we found almost 8-fold more NADP-
dependent ADH activity with ethanol as substrate in lysates of E.
histolytica HM-1:IMSS than in lysates of E. dispar. These data are
consistent with higher levels of EhADH3 in E. histolytica than E.
dispar, but we cannot be absolutely certain that all of the NADP-
dependent ADH activity in these lysates (with ethanol as substrate)
is secondary to the Entamoeba ADH3 enzyme family.
As a first step towards determining whether EhADH3 could
play a role in E. histolytica virulence we performed immunolocal-
ization studies using polyclonal antiserum to recombinant
EhADH3 with live trophozoites. As shown in Figure 7, some
EhADH3 was localized to the surface of live E. histolytica HM-
1:IMSS trophozoites, and pre-incubation of the anti-EhADH3
antibodies with recombinant EhADH3 prior to staining signifi-
cantly inhibited their ability to bind to the trophozoites’ surface.
Figure 6. Recombinant EhADH3 prefers straight chain alcohols as a substrate. An enzymatic substrate preference assay was conducted to
determine the optimal substrate for recombinant EhADH3. Butanol was demonstrated to be the preferred substrate, followed by shorter straight-
chain alcohols. Branched alcohols were not detectably processed by recombinant EhADH3.
doi:10.1371/journal.pntd.0000415.g006
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These data indicate that at least some of the EhADH3 is on the
surface of E. histolytica trophozoites, increasing the likelihood of
interactions with host molecules. We used the same antibodies to
determine whether ADH3 could be detected on the surface of E.
dispar, and saw a similar staining pattern, but with much decreased
overall intensity (data not shown).
We also explored whether EhADH3 might play some role in
trophozoite adherence to host cells or host macromolecules due to
its presence on the amebic plasma membrane. Some bacterial
dehyrogenases have also been surface-localized and linked to
adherence, including the S. pneumoniae 6-phosphogluconate-
dehydrogenase, which mediates binding to buccal epithelial cells
[35]. However, we were unable to show direct binding of
EhADH3 to either sepharose-coupled fibronectin or laminin (data
not shown), and polyclonal antiserum to recombinant EhADH3
failed to inhibit E. histolytica HM-1:IMSS trophozoites from
binding to Chinese Hamster Ovary cells (data not shown) [36].
To further examine the potential role of EhADH3 in E.
histolytica virulence, E. histolytica HM-1:IMSS trophozoites and E.
histolytica trophozoites of the reduced virulence E. histolytica
Rahman strain were transfected with a plasmid designed to
overexpress EhADH3. Immunoblotting of lysates from wild type
and transfected trophozoites with antibodies to EhADH3
confirmed successful overexpression of EhADH3 in the transfec-
tants (Figure 8). Based on densitometry, EhADH3 was overex-
pressed approximately 2-fold in transfected E. histolytica HM-
1:IMSS and E. histolytica Rahman. As a physiologic measure for
EhADH3 overexpression, we quantified NADP-dependent alcohol
dehydrogenase activity in lysates from wild-type or transfected E.
histolytica HM-1:IMSS trophozoites using butanol as a substrate.
Transfected amebae had 3.1-fold more NADP-dependent alcohol
dehydrogenase activity than the wild type control, confirming
overexpression of functional enzyme (Table 1).
We then examined whether E. histolytica HM-1:IMSS tropho-
zoites overexpressing EhADH3 would show increased virulence in
the SCID mouse model of amebic liver abscess. While we saw
slightly larger abscesses in livers from mice inoculated with E.
histolytica HM-1:IMSS overexpressing EhADH3 (n = 11, mean
abscess size of 38616% of liver abscessed) compared with the
parental wild type E. histolytica HM-1:IMSS strain (n = 11, mean
abscess size of 30617% of liver abscessed), this difference was not
statistically significant (P = 0.25). We then looked at whether
overexpression of EhADH3 in E. histolytica Rahman would alter
the ability of this strain to cause amebic liver abscesses in mice. We
were unable to detect any increase in the size or presence of
amebic liver abscesses in mice undergoing liver challenge with E.
histolytica Rahman transfected with EhADH3 compared to
challenge with either wildtype E. histolytica Rahman trophozoites
or E. histolytica Rahman trophozoites expressing the pNEO control
plasmid (data not shown).
In order to study phenotypic effects in colonic disease, we
employed the SCID-hu human intestinal xenograft mouse model
of amebic colitis [21]. We observed a statistically significant
difference in the amount of intestinal inflammation (as measured
by the levels of myeloperoxidase) in human intestinal xenografts
infected with E. histolytica Rahman trophozoites expressing
EhADH3 (N=10, mean of 1.7560.8 units MPO/mg total
protein), compared to either human intestinal xenografts infected
with either E. histolytica Rahman trophozoites transfected with the
pNEO control plasmid (N=10, mean of 0.860.7 units MPO/mg
Figure 7. Live immuofluoresent surface staining of EhADH3
reveals its presence on the plasma membrane surface of E.
histolytica HM-1:IMSS. Amebae were harvested at 4uC, then blocked
with blocking buffer for 10 min prior to staining with rabbit polyclonal
anti-EhADH3 antibodies (panels A,B,C) or staining with antibodies pre-
incubated with a molar excess of recombinant EhADH3 (panels D,E,F).
Panels A and D show staining with the AlexaFlour secondary antibody,
panels B and E the brightfield image, and panels C and F are a merge of
the two. Magnification 636.
doi:10.1371/journal.pntd.0000415.g007
Figure 8. Western blot confirmation of EhADH3 overexpres-
sion in transfected E. histolytica. E. histolytica strain E. histolytica HM-
1:IMSS was transfected to overexpress EhADH3 Lysates from the parent
strain (E. histolytica HM-1:IMSS), the pNEO control transfectant (HN), and
the transfectants overexpressing EhADH3 (HAO) were separated on an
SDS-PAGE gel, blotted to PVDF, and stained with polyclonal anti-
EhADH3 antibodies (top panel) or anti-actin antibodies (bottom panel).
A similar experiment was performed for transfectants overexpressing
EhADH3 in E. histolytica Rahman (right upper and lower panels). Lysates
from the parent E. histolytica Rahman strain (Rahman), the pNEO control
transfectant (RN) and tranfectants overexpressing EhADH3 were
processed as above.
doi:10.1371/journal.pntd.0000415.g008
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total protein, P,0.05) or wildtype E. histolytica Rahman tropho-
zoites (N= 10, mean of 0.660.5 units MPO/mg total protein,
P,0.01). Using our assay for damage to the intestinal permeability
barrier [22], we were unable to detect any statistically significant
differences between human intestinal xenografts infected with E.
histolytica Rahman trophozoites expressing EhADH3 and human
intestinal xenografts infected with either control, nor any obvious
histological differences in sections from infected intestinal
xenografts (data not shown). Interpretation of all of these results
is complicated by the fact that we were only able to obtain an
approximately 2-fold increase in EhADH3 production, and this
may have been insufficient to detect a phenotypic difference
between tranfectants and controls. Expression of antisense
constructs did not reduce EhADH3 levels in E. histolytica HM-
1:IMSS (data not shown).
In summary, our proteomic comparisons identified a number of
differences between the virulent E. histolytica HM-1:IMSS and the
commensal E. dispar. However, when we limited our analysis to
those spots that showed the greatest magnitude difference and
were consistently reproduced, we identified 4 proteins that were
differentially expressed between the two species. Remarkably, 3 of
the 4 were identical to proteins identified in a comparison of E.
histolytica HM-1:IMSS and the reduced virulence E. histolytica
Rahman strain [3]. This may reflect both a potential role for these
proteins in virulence, as well as their relative abundance and
electrophoretic properties.
We focused our efforts on characterizing one of the proteins
expressed at higher levels in E. histolytica HM-1:IMSS, EhADH3.
We found that EhADH3 does possess alcohol dehydrogenase
activity but, unexpectedly, can be localized to the trophozoite
surface. However, we were not able to detect an adherence
function for EhADH3, and an approximate two-fold overexpres-
sion of EhADH3 in E. histolytica HM-1:IMSS failed to result in
increased virulence. A three-fold overexpression of the EhADH3
gene in the reduced virulence E. histolytica strain E. histolytica
Rahman also did not lead to trophozoites capable of causing
increased tissue damage in animal models of amebic liver abscess
or amebic colitis; however, it did lead to an increased
inflammatory response. Thus, while EhADH3 is more abundant
in E. histolytica HM-1:IMSS than either E. dispar or E. histolytica
Rahman, we cannot directly link EhADH3 to the increased
virulence of E. histolytica HM-1:IMSS.
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